Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.

2.

Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.

Vemuri VK, Janero DR, Makriyannis A.

Physiol Behav. 2008 Mar 18;93(4-5):671-86. Epub 2007 Nov 21. Review.

3.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

PMID:
15550444
4.

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

Anand P, Whiteside G, Fowler CJ, Hohmann AG.

Brain Res Rev. 2009 Apr;60(1):255-66. doi: 10.1016/j.brainresrev.2008.12.003. Epub 2008 Dec 25. Review.

5.

The endocannabinoid system as a target for the treatment of motor dysfunction.

Fernández-Ruiz J.

Br J Pharmacol. 2009 Apr;156(7):1029-40. doi: 10.1111/j.1476-5381.2008.00088.x. Epub 2009 Feb 13. Review.

6.

Cannabinoids.

Grotenhermen F.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):507-30. Review.

PMID:
16266285
7.

In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

Giuffrida A, McMahon LR.

Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):90-103. doi: 10.1016/j.prostaglandins.2009.05.004. Epub 2009 Jun 10. Review.

8.

Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.

Basavarajappa BS, Nixon RA, Arancio O.

Mini Rev Med Chem. 2009 Apr;9(4):448-62. Review.

9.

The endocannabinoid system in neurodegeneration.

Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M.

Ital J Biochem. 2006 Sep-Dec;55(3-4):283-9. Review.

PMID:
17274532
10.

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.

Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA.

Life Sci. 2010 Apr 10;86(15-16):615-23. doi: 10.1016/j.lfs.2009.06.003. Epub 2009 Jun 13. Review.

11.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
12.

The endocannabinoid system and pain.

Guindon J, Hohmann AG.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21. Review.

13.

An introduction to the endocannabinoid system: from the early to the latest concepts.

De Petrocellis L, Di Marzo V.

Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):1-15. doi: 10.1016/j.beem.2008.10.013. Review.

PMID:
19285257
14.

Endocannabinoid system modulation in cancer biology and therapy.

Pisanti S, Bifulco M.

Pharmacol Res. 2009 Aug;60(2):107-16. doi: 10.1016/j.phrs.2009.03.011. Epub 2009 Mar 24. Review.

PMID:
19559362
15.

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.

Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A, Bernstein Y, Thomas KJ, Kim E, Walker JM, Nagar S, Ward SJ, Raffa RB.

J Clin Pharm Ther. 2007 Jun;32(3):209-31. Review.

PMID:
17489873
16.

Cannabinoid receptors and their ligands.

Pertwee RG, Ross RA.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):101-21. Review.

PMID:
12052030
17.

Therapeutic potential of the endocannabinoid system in the brain.

Ramos JA, González S, Sagredo O, Gómez-Ruiz M, Fernández-Ruiz J.

Mini Rev Med Chem. 2005 Jul;5(7):609-17. Review.

PMID:
16026307
18.

The emerging role of the endocannabinoid system in cardiovascular disease.

Pacher P, Steffens S.

Semin Immunopathol. 2009 Jun;31(1):63-77. doi: 10.1007/s00281-009-0145-8. Epub 2009 Apr 9. Review.

19.

Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.

Gertsch J.

Planta Med. 2008 May;74(6):638-50. doi: 10.1055/s-2008-1034302. Epub 2008 Feb 14. Review.

PMID:
18275004
20.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678

Supplemental Content

Support Center